Best Practices in Cardiology 2015-Rhythm to Revival Series

Home
Best Practices in Cardiology 2015-Rhythm to Revival Series

A one of its kind clinical case based Cardiology conference hosted by Medanta - the Medicity in association with Mayo Clinic USA

07/09/2015

Here's what Dr. Sorin V. Pislaru had to say about his experience at the 'Best Practices in 2015 - Rhythm to Revival Series' jointly organised by Medanta - The Medicity and Mayo Clinic and key points of his sessions

07/09/2015

Here's a look at of the Best Practices in Cardiology 2015 - Rhythm to Revival Series

The conference organized jointly by Medanta, The Medicity and Mayo Clinic was attended by renowned faculty members from across the Globe and saw interesting discussions on the innovations in Cardiology, the future of cardiac treatment and the ongoing controversies. We now look forward to the conference next year!

06/09/2015

Glimpses of at the Best Practices in Cardiology 2015 - Rhythm to Revival Series

06/09/2015

A tete a tete with Dr Helmut Purerfellner from Mayo Clinic on his visit to India, feedback on the conference and key points from his sessions

06/09/2015

Here is a synopsis of what Dr Rajeev Agarwala had to say this morning during his session on Statins in the last two decades, what is the real truth

06/09/2015

Here is a synopsis of Dr KK Tripathi's talk on role of Gliptins in Diabetes and CVD risk at the Best Practices in Cardiology 2015 - Rhythm to Revival series

06/09/2015

And the conference comes to a close, all the delegates give a standing ovation to Dr Balbir Singh for organizing such a fantastic feast of academic excellence !

06/09/2015

Dr. Gurpreet Sandhu discuses future of intervention in structural heart disease. According to him "magnetic navigation and robotic are very expensive but useful technologies"

06/09/2015

Dr. K.K. Tripathi discusses Role of Gliptins in diabetes and CVD risk. According to him "Spending on diabetes is predicted to triple between 2009 and 2034."

06/09/2015

Dr. Balbir singh discusses NAOC's are here to stay in prevention of stroke in AF. According to him "in patients with atrial fibrillation, apixaban is superior to warfarin at preventing stroke or systematic embolism, causes less bleeding, and results in lower mortality."

06/09/2015

with Dr Malcolm Bell from Mayo Clinic

- 68 year old female hospitalized for 48 hours with recent NSTEMI and treated with UFH
- PMHx, DM2, CKD stage 3B
- Transferred for CA and possible PCI
- UFH continued and loaded with clopidogrel
- Labs on arrival - Platelets 300 x 10'9L and creatinine 3.0mg/dl

What would you recommend?
1) Nothing - continue UFH
2) Switch to LMWH
3) Discontinue UFH and check ELISA - Ab to PF4 heparin complex
4) Discontinue UFH and start bivalirudin
5) Discontinue UFH and start argatroban

Correct answer 5 - Here is what the audience polled

06/09/2015

Dr Jagat Narula,Associate Dean for Global Health at the Icahn School of Medicine at Mount Sinai discusses ' Do we need genetic information for all cardiomyopathies'

Address

JW Marriot Aerocity

110037

Telephone

+911145212121

Website

http://theheartpedia.com/

Alerts

Be the first to know and let us send you an email when Best Practices in Cardiology 2015-Rhythm to Revival Series posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Want your practice to be the top-listed Clinic?

Country:

City:

07/09/2015

07/09/2015

06/09/2015

06/09/2015

06/09/2015

06/09/2015

06/09/2015

06/09/2015

06/09/2015

06/09/2015

06/09/2015

06/09/2015

Address

Telephone

Website

Alerts

Shortcuts

Share